🧵 3. Sales of Eli Lilly's breast cancer pill Verzenio rose 57% to $926.8 million in Q2, driving a 28% revenue increase from last year.
You are viewing a single comment's thread from:
🧵 3. Sales of Eli Lilly's breast cancer pill Verzenio rose 57% to $926.8 million in Q2, driving a 28% revenue increase from last year.